Medcrypt Launches Intelligence Platform to Transform Medical Device Cybersecurity

Medcrypt, the leading provider of proactive cybersecurity solutions for medical devices, announced today a major milestone in its continued growth, fuele...

May 30, 2025 | Friday | News
Danaher and AstraZeneca Partner to Advance AI-Powered Diagnostics for Precision Medicine

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powe...

May 30, 2025 | Friday | News
Alzamend Doses First Patient in Phase II Trial of AL001, Aiming to Transform Lithium Therapy for Neurological Disorders

Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithi...

May 30, 2025 | Friday | News
Candel Therapeutics Secures FDA RMAT Designation for CAN-2409 in Localized Prostate Cancer

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological ...

May 29, 2025 | Thursday | News
SCYNEXIS Resumes Dosing in Phase 3 MARIO Study for Invasive Candidiasis Following FDA Clinical Hold Lift

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infe...

May 29, 2025 | Thursday | News
Altamira Enters Collaboration to Explore CycloPhore™ Delivery of Circular RNA Therapeutics

Exploring use of Altamira’s RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negoti...

May 28, 2025 | Wednesday | News
Liebherr Expands Scientific Line with New Combination Refrigerator-Freezer for Laboratories

Liebherr USA, Co. refrigerators and freezers is excited to announce the addition of a new combination refrigerator-freezer to its scientific appliance li...

May 27, 2025 | Tuesday | News
Celltrion Secures Full Interchangeability Designation for YUFLYMA® Across All Adalimumab Dosage Forms in the U.S.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimil...

May 27, 2025 | Tuesday | News
Avance Clinical Empowers US Biotechs With GlobalReady Program Amid Regulatory Uncertainty at Home

As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-p...

May 27, 2025 | Tuesday | News
Invivyd’s PEMGARDA® Added to NCCN Guidelines for B-Cell Lymphomas Amid Ongoing COVID-19 Risk

Invivyd, Inc. announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Net...

May 26, 2025 | Monday | News
Sanofi Opens $130M U.S. Flagship Office in Morristown to Drive Innovation, Collaboration, and Community Impact

Sanofi  announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration...

May 23, 2025 | Friday | News
Astellas and Pfizer’s XTANDI Demonstrates 30% Reduced Risk of Death at Five Years in mHSPC Patients

Astellas Pharma Inc. (TSE: 4503) and Pfizer Inc. (NYSE: PFE)  announced compelling five-year overall survival (OS) results from the open-label exten...

May 23, 2025 | Friday | News
Ecolab’s Strategic Move in Pennsylvania: A Catalyst for Biotherapeutic Innovation

  In this exclusive interview with BioPharma BoardRoom, Jessay Devassy, Manager, Bioprocess Applications at Ecolab Bioprocessing&...

May 23, 2025 | Friday | Interaction
Eli Lilly’s Kisunla™ (donanemab) Receives Marketing Authorization in Australia for Early Alzheimer’s Treatment

 Eli Lilly and Company  announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for Kisunla (d...

May 22, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close